Yuze Ma , Gao F
Cancer Imaging. 2024; 24(1):19.
PMID: 38279185
PMC: 10811881.
DOI: 10.1186/s40644-024-00658-y.
Trencsenyi G, Kepes Z
Int J Mol Sci. 2023; 24(8).
PMID: 37108559
PMC: 10138813.
DOI: 10.3390/ijms24087400.
Sigorski D, Wesolowski W, Gruszecka A, Gulczynski J, Zielinski P, Misiukiewicz S
J Cancer Res Clin Oncol. 2022; 149(9):5803-5822.
PMID: 36583743
PMC: 10356636.
DOI: 10.1007/s00432-022-04540-x.
Kalman-Szabo I, Szabo J, Arato V, Denes N, Opposits G, Joszai I
Int J Mol Sci. 2022; 23(17).
PMID: 36077458
PMC: 9456106.
DOI: 10.3390/ijms231710061.
Romantini N, Alam S, Dobitz S, Spillmann M, De Foresta M, Schibli R
Proc Natl Acad Sci U S A. 2021; 118(48).
PMID: 34810259
PMC: 8640787.
DOI: 10.1073/pnas.2108776118.
More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond.
Hyvakka A, Virtanen V, Kemppainen J, Gronroos T, Minn H, Sundvall M
Cancers (Basel). 2021; 13(9).
PMID: 34067046
PMC: 8125679.
DOI: 10.3390/cancers13092244.
First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist Ga-NODAGA-MJ9.
Gnesin S, Cicone F, Mitsakis P, Van Der Gucht A, Baechler S, Miralbell R
EJNMMI Res. 2018; 8(1):108.
PMID: 30543050
PMC: 6291411.
DOI: 10.1186/s13550-018-0462-9.
GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression.
Solorzano S, Imaz-Rosshandler I, Camacho-Arroyo I, Garcia-Tobilla P, Morales-Montor G, Salazar P
Sci Rep. 2018; 8(1):10272.
PMID: 29980692
PMC: 6035255.
DOI: 10.1038/s41598-018-28538-z.
Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors.
Baratto L, Jadvar H, Iagaru A
Mol Imaging Biol. 2017; 20(4):501-509.
PMID: 29256046
PMC: 7469490.
DOI: 10.1007/s11307-017-1151-1.
Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?.
Grigore A, Ben-Jacob E, Farach-Carson M
Front Oncol. 2015; 5:37.
PMID: 25785244
PMC: 4347593.
DOI: 10.3389/fonc.2015.00037.
β-Adrenergic Receptor Signaling in Prostate Cancer.
Braadland P, Ramberg H, Grytli H, Tasken K
Front Oncol. 2015; 4:375.
PMID: 25629002
PMC: 4290544.
DOI: 10.3389/fonc.2014.00375.
PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.
Rybalov M, Ananias H, Hoving H, van der Poel H, Rosati S, de Jong I
Int J Mol Sci. 2014; 15(4):6046-61.
PMID: 24727373
PMC: 4013614.
DOI: 10.3390/ijms15046046.
Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.
Patrikidou A, Vlachostergios P, Voutsadakis I, Hatzidaki E, Valeri R, Destouni C
Cancer Cell Int. 2012; 12(1):31.
PMID: 22715899
PMC: 3441896.
DOI: 10.1186/1475-2867-12-31.
Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells.
Jones S, Palmer T
Cell Signal. 2012; 24(8):1504-14.
PMID: 22504159
PMC: 3510439.
DOI: 10.1016/j.cellsig.2012.03.018.
Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.
Fournier P, Dumulon-Perreault V, Ait-Mohand S, Langlois R, Benard F, Lecomte R
EJNMMI Res. 2012; 2:8.
PMID: 22333272
PMC: 3323469.
DOI: 10.1186/2191-219X-2-8.
Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading.
Chen P, Kroog G
Cell Adh Migr. 2010; 4(4):527-40.
PMID: 20543562
PMC: 3011259.
DOI: 10.4161/cam.4.4.12399.
A phase I trial of the bombesin/gastrin-releasing peptide (BN/GRP) antagonist RC3095 in patients with advanced solid malignancies.
Schwartsmann G, DiLeone L, Horowitz M, Schunemann D, Cancella A, Pereira A
Invest New Drugs. 2006; 24(5):403-12.
PMID: 16505950
DOI: 10.1007/s10637-006-6886-5.
Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.
Qiao J, Kang J, Cree J, Evers B, Chung D
Ann Surg. 2005; 241(5):684-91.
PMID: 15849504
PMC: 1357123.
DOI: 10.1097/01.sla.0000161173.47717.71.
Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression.
Dawson L, Maitland N, Turner A, Usmani B
Br J Cancer. 2004; 90(8):1577-82.
PMID: 15083188
PMC: 2409712.
DOI: 10.1038/sj.bjc.6601717.
Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer.
Constantinides C, Lazaris A, Haritopoulos K, Pantazopoulos D, Chrisofos M, Giannopoulos A
World J Urol. 2003; 21(3):183-7.
PMID: 12845460
DOI: 10.1007/s00345-003-0339-y.